The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the area of immunogenicity.
Its mission is to build know-how and expertise in the field of immunogenicity, driven by a close interaction between industry and scientific advisors.
The European Immunogenicity Platform represents companies, institutes and professionals involved in research, development, testing, validation, application, production or marketing of immunogenicity assessment tools, as well as those servicing the biotechnology community.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Kortestraat 62, Welle,flemish Region 9473,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.e-i-p.eu/
- Keywords
- EMBL-EBI Chemical Biology Services.
- HQ
- Welle, Flemish Region
Eip European Immunogenicity Platform Questions
Eip European Immunogenicity Platform's website is https://www.e-i-p.eu/
Eip European Immunogenicity Platform's LinkedIn profile is https://be.linkedin.com/company/eip-european-immunogenicity-platform
Eip European Immunogenicity Platform has
2 employees.
View email and phone details for 2
employees at Eip European Immunogenicity Platform.
Eip European Immunogenicity Platform's industry is
Biotechnology Research
Eip European Immunogenicity Platform's top competitors are
Bioagilytix,
Biontech Se,
Embl-Ebi Chemical Biology Services,
Centerfirst,
Large Molecule Bioanalysis Advice,
Immunogenicity Integrated,
Australian Stroke And Heart Research Accelerator (Ashra),
The Overview,
Guy Howland Ltd,
Therawis Diagnostics Gmbh.
Eip European Immunogenicity Platform's categories are Biotechnology Research
Eip European Immunogenicity Platform's founding year is 2007
